Ten studies from 2013 with potential to change endocrinology practice were summarized in Annals of Internal Medicine's annual Update in Endocrinology, published in the June 3 issue.
The recommendations from the American Diabetes Association and the European Association for the Study of Diabetes encourage use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists.
Integrated care model offers noninferior diabetes care to gold-standard specialist clinics | ACP Diabetes Monthly
A study conducted in Australia found that general practitioners with specialization in diabetes care and subspecialist-led clinics reduced HbA1c levels by similar amounts in patients with complex type 2 diabetes.
Patients with late-onset type 1 diabetes commonly treated as having type 2 diabetes | ACP Diabetes Monthly
An analysis of patients with insulin-treated diabetes found that 38% of those with late-onset type 1 diabetes did not receive insulin at diagnosis, nearly half of whom reported a type 2 diabetes diagnosis.
Metformin associated with more long-term weight loss than lifestyle change in prediabetes patients | ACP Diabetes Monthly
Other independent predictors of long-term weight loss included greater weight loss in the first year and older age, according to this follow-up analysis of the Diabetes Prevention Program.
They pointed out that almost 50% of patients with diabetes have severe periodontitis and that their findings “highlight the potential to improve metabolic control and possibly diabetes outcomes by addressing poor
Adults with diabetes should be referred to individualized, diabetes-focused medical nutrition therapy, while overweight or obese adults with prediabetes should be referred to an intensive lifestyle intervention program and/or medical nutritional
Oral semaglutide led to greater reductions in HbA1c, body weight than sitagliptin | ACP Diabetes Monthly
The industry-funded PIONEER 3 trial randomized adults whose type 2 diabetes was uncontrolled with metformin, with or without sulfonylurea, to receive either oral sitagliptin (100 mg/d) or oral semaglutide (3, 7, or 14 mg/d).
Early subspecialist involvement led to reduced infections among inpatients with diabetes | ACP Diabetes Monthly
Researchers studied an early intervention model in which an inpatient diabetes team electronically identified patients with hyperglycemia and aimed to provide bedside management within 24 hours of admission, compared with a referral-based
Insulin initiation in the hospital associated with death, ED visits, readmissions in older patients | ACP Diabetes Monthly
While we could not determine causality between insulin and mortality, we highlight a vulnerable population which needs additional resources in the discharge transition period,” the authors wrote.